E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/1/2006 in the Prospect News PIPE Daily.

New Issue: Byotrol settles £5 million private placement of shares

By Laura Lutz

Des Moines, Nov. 1 - Byotrol plc closed a private placement of shares for £5.004 million.

The company sold 8.34 million ordinary shares at 60p each.

Charles Stanley Securities acted as agent for the deal.

Proceeds will be used for business opportunities in the health care, food processing and industrial and technical markets.

Byotrol is an antimicrobial technology company based in Manchester, England.

Issuer:Byotrol plc
Issue:Ordinary shares
Amount:£5.004 million
Shares:8.34 million
Price:60p
Warrants:No
Agent:Charles Stanley Securities
Settlement date:Nov. 1
Stock symbol:London: BYOT
Stock price:72.5p at close Oct. 31

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.